Difference between revisions of "Collaborator:Resources"

From NAMIC Wiki
Jump to: navigation, search
Line 14: Line 14:
  
 
'''Please note key dates:''' Opening Date: September 5, 2008. After that, all [http://grants1.nih.gov/grants/funding/submissionschedule.htm standard NIH submission dates] for R21s and R01s apply to this grant.
 
'''Please note key dates:''' Opening Date: September 5, 2008. After that, all [http://grants1.nih.gov/grants/funding/submissionschedule.htm standard NIH submission dates] for R21s and R01s apply to this grant.
 +
 +
*Notes 2010-03:
 +
**New [http://grants.nih.gov/grants/funding/424/index.htm forms]
 +
**New structure: (page 108 of the pdf version)
 +
***1 page specific aims
 +
***6/12 pages for research strategy
 +
***(a) Significance: Explain the importance of the problem or critical barrier to
 +
****progress in the field that the proposed project addresses.
 +
****Explain how the proposed project will improve scientificknowledge, technical capability, and/or clinical practice in one or more broad fields.
 +
****Describe how the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field will be changed if the proposed aims are achieved.
 +
***(b) Innovation
 +
****Explain how the application challenges and seeks to shift current research or clinical practice paradigms.
 +
****Describe any novel theoretical concepts, approaches or methodologies, instrumentation or interventions to be developed or used, and any advantage over existing methodologies, instrumentation, or interventions.
 +
****Explain any refinements, improvements, or new applications of theoretical concepts, approaches or methodologies, instrumentation, or interventions.
 +
***(c) Approach
 +
****Describe the overall strategy, methodology, and analyses to be used to accomplish the specific aims of the project. Unless addressed separately in Item 15 (Resource Sharing Plan), include how the data will be collected, analyzed, and interpreted as well as any resource sharing plans as appropriate.
 +
****Discuss potential problems, alternative strategies, and benchmarks for success anticipated to achieve the aims.
 +
****If the project is in the early stages of development, describeany strategy to establish feasibility, and address the management of any high risk aspects of the proposed work.
 +
****Point any procedures, situations, or materials that may behazardous to personnel and precautions to be exercised. A full discussion on the use of Select Agents should appear in Item 11, below.

Revision as of 16:05, 2 March 2010

Home < Collaborator:Resources
Back to NA-MIC Collaborations
  • This page contains information for prospective external collaborators. NIH has established funding sources for collaborating with the NCBC's.
  • Click here for a description of the process for collaborating with NA-MIC. This should be read first.

Please contact us if you are interested in a collaborative project with NA-MIC.

  • In addition to contacting the center, you are encouraged to contact the NIH Program Officer Zohara Cohen, Ph.D. (NIBIB) or the Lead Science Officer Michael Ackermann, Ph.D. (NLM) for NA-MIC.

Please note key dates: Opening Date: September 5, 2008. After that, all standard NIH submission dates for R21s and R01s apply to this grant.

  • Notes 2010-03:
    • New forms
    • New structure: (page 108 of the pdf version)
      • 1 page specific aims
      • 6/12 pages for research strategy
      • (a) Significance: Explain the importance of the problem or critical barrier to
        • progress in the field that the proposed project addresses.
        • Explain how the proposed project will improve scientificknowledge, technical capability, and/or clinical practice in one or more broad fields.
        • Describe how the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field will be changed if the proposed aims are achieved.
      • (b) Innovation
        • Explain how the application challenges and seeks to shift current research or clinical practice paradigms.
        • Describe any novel theoretical concepts, approaches or methodologies, instrumentation or interventions to be developed or used, and any advantage over existing methodologies, instrumentation, or interventions.
        • Explain any refinements, improvements, or new applications of theoretical concepts, approaches or methodologies, instrumentation, or interventions.
      • (c) Approach
        • Describe the overall strategy, methodology, and analyses to be used to accomplish the specific aims of the project. Unless addressed separately in Item 15 (Resource Sharing Plan), include how the data will be collected, analyzed, and interpreted as well as any resource sharing plans as appropriate.
        • Discuss potential problems, alternative strategies, and benchmarks for success anticipated to achieve the aims.
        • If the project is in the early stages of development, describeany strategy to establish feasibility, and address the management of any high risk aspects of the proposed work.
        • Point any procedures, situations, or materials that may behazardous to personnel and precautions to be exercised. A full discussion on the use of Select Agents should appear in Item 11, below.